Buddhadeb Dawn

Author PubWeight™ 88.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007 6.68
2 Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012 4.56
3 Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010 3.42
4 Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 2004 2.50
5 Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res 2008 2.31
6 Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits. J Am Coll Cardiol 2003 2.23
7 Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 2003 2.22
8 Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res 2002 1.90
9 A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J Mol Cell Cardiol 2011 1.79
10 Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA My Heart Study. J Am Coll Cardiol 2013 1.77
11 The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning. J Mol Cell Cardiol 2008 1.61
12 Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004 1.56
13 Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J Mol Cell Cardiol 2003 1.45
14 Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovasc Res 2010 1.45
15 Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol 2006 1.32
16 Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice. Circ Res 2009 1.32
17 Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction. J Mol Cell Cardiol 2008 1.28
18 FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy. Am J Physiol Endocrinol Metab 2013 1.26
19 Morphological characterization of very small embryonic-like stem cells (VSELs) by ImageStream system analysis. J Cell Mol Med 2007 1.26
20 Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction. J Cell Mol Med 2010 1.25
21 Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med 2003 1.20
22 Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation 2008 1.17
23 Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders. J Am Coll Cardiol 2012 1.16
24 Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway. Circulation 2009 1.15
25 Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway. Circulation 2007 1.15
26 Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J 2008 1.15
27 Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min. Am J Physiol Heart Circ Physiol 2006 1.13
28 Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 2004 1.12
29 Pulmonary vein stenosis due to a compressive malignant tumor detected by transesophageal echocardiography. Circulation 2011 1.11
30 Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences. Am J Physiol Heart Circ Physiol 2005 1.09
31 Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits. Circulation 2005 1.06
32 The late phase of preconditioning and its natural clinical application--gene therapy. Heart Fail Rev 2007 1.02
33 Delayed adaptation of the heart to stress: late preconditioning. Stroke 2004 1.01
34 HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection? Am J Physiol Heart Circ Physiol 2005 1.00
35 Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome-the heart to gut connection! J Interv Card Electrophysiol 2013 0.98
36 Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. J Mol Cell Cardiol 2011 0.97
37 Noncanonical Wnt11 signaling and cardiomyogenic differentiation. Trends Cardiovasc Med 2008 0.96
38 Radiofrequency ablation of atrial fibrillation in patients with mitral or aortic mechanical prosthetic valves: a feasibility, safety, and efficacy study. Heart Rhythm 2011 0.94
39 Risk factors for coronary heart disease in Indians: a case-control study from Eastern India. Indian Heart J 2006 0.93
40 No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis. Int J Cardiol 2012 0.91
41 Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond. Basic Res Cardiol 2011 0.91
42 TGF-beta1 enhances cardiomyogenic differentiation of skeletal muscle-derived adult primitive cells. Basic Res Cardiol 2008 0.90
43 Impact of nonfluoroscopic MediGuide™ tracking system on radiation exposure in radiofrequency ablation procedures (LESS-RADS registry)-an initial experience. J Interv Card Electrophysiol 2013 0.90
44 Congenital ostial left main coronary artery stenosis associated with a bicuspid aortic valve in a young woman. J Invasive Cardiol 2006 0.89
45 Sca-1 expression is associated with decreased cardiomyogenic differentiation potential of skeletal muscle-derived adult primitive cells. J Mol Cell Cardiol 2006 0.88
46 Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction. PLoS One 2011 0.84
47 Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol 2011 0.84
48 Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol 2011 0.84
49 Impact of valvular calcification on the diagnostic accuracy of transesophageal echocardiography for the detection of congenital aortic valve malformation. Echocardiography 2007 0.84
50 Cardiac progenitor cells: the revolution continues. Circ Res 2005 0.83
51 Very small embryonic-like stem cells: biology and therapeutic potential for heart repair. Antioxid Redox Signal 2011 0.82
52 Exercise tolerance is reduced in bipolar illness. J Affect Disord 2007 0.82
53 Wnt signaling and cardiac differentiation. Prog Mol Biol Transl Sci 2012 0.81
54 Acquired aortic cusp fusion after chronic left ventricular assist device support. J Am Soc Echocardiogr 2006 0.81
55 Bone marrow cell-mediated cardiac regeneration a veritable revolution. J Am Coll Cardiol 2005 0.80
56 Clinical utility and prognostic significance of measuring troponin I levels in patients presenting to the emergency room with atrial fibrillation. Clin Cardiol 2014 0.79
57 The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up. J Mol Cell Cardiol 2009 0.79
58 The cornucopia of "pleiotropic" actions of statins: myogenesis as a new mechanism for statin-induced benefits? Circ Res 2009 0.79
59 Increasing evidence that estrogen is an important modulator of bone marrow-mediated cardiac repair after acute infarction. Circulation 2006 0.79
60 Images in cardiovascular medicine. Dehiscence of mitral annuloplasty ring. Circulation 2005 0.79
61 Bone marrow cells for cardiac regeneration: the quest for the protagonist continues. Cardiovasc Res 2005 0.78
62 Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time? J Interv Card Electrophysiol 2014 0.78
63 Tricuspid regurgitation: pathophysiology and management. Curr Cardiol Rep 2012 0.78
64 Recurrent aortic dissection in Marfan's syndrome: possible effects of anticoagulation. Cardiol Rev 2003 0.77
65 Cardiac manifestations of exhaustive exercise in nonathletic adults: does cardiac fatigue occur? Echocardiography 2007 0.77
66 Clinical trials of cardiac repair with adult bone marrow- derived cells. Methods Mol Biol 2013 0.77
67 Impact and predictors of noncircular left ventricular outflow tract shapes on estimating aortic stenosis severity by means of continuity equations. Tex Heart Inst J 2015 0.76
68 Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device. J Interv Card Electrophysiol 2015 0.76
69 Resveratrol: ready for prime time? J Mol Cell Cardiol 2007 0.75
70 Pulmonary emboli in transit. J Gen Intern Med 2012 0.75
71 Response to letter regarding article, "Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis". Circulation 2013 0.75
72 Preconditioning by angiotensin II: a tale of more than two kinases. J Mol Cell Cardiol 2006 0.75
73 G-CSF and erythropoietin combination therapy for infarct repair: two plus two equals two? Editorial to: "Cytokine combination theray with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction" by F.S. Angeli et al. Cardiovasc Drugs Ther 2010 0.75
74 Intravenous Adenosine Infusion is Safe and Well Tolerated During Coronary Fractional Flow Reserve Assessment in Elderly Patients With Severe Aortic Stenosis. J Invasive Cardiol 2016 0.75
75 Acute myocardial infarction in a 19 year-old female owing to hypercoagulable state of pregnancy and the puerperium. J Invasive Cardiol 2008 0.75
76 Partial Brain Tissue Oxygen Levels Predict Arrhythmia and Prognosis in Patients With Brain Injury. Am J Ther 2016 0.75
77 Optimal Medical Management Reduces Risk of Disease Progression and Ischemic Events in Asymptomatic Carotid Stenosis Patients: A Long-Term Follow-Up Study. Cerebrovasc Dis 2017 0.75
78 Iatrogenic submedial coronary artery intramural hematoma presenting subacutely. J Invasive Cardiol 2009 0.75
79 Hypotension during dobutamine stress transesophageal echocardiography: relationship with provoked left ventricular obstruction. J Am Soc Echocardiogr 2006 0.75
80 Inverse Correlation of Venous Brain Natriuretic Peptide Levels with Body Mass Index Is due to Decreased Production. Cardiology 2017 0.75